Moors & Cabot Inc. lowered its holdings in Healthpeak Properties, Inc. (NYSE:PEAK) by 10.4% in the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 6,195 shares of the company’s stock after selling 722 shares during the period. Moors & Cabot Inc.’s holdings in Healthpeak Properties were worth $206,000 as of its most recent SEC filing.
Several other hedge funds have also modified their holdings of the company. Cohen & Steers Inc. lifted its stake in shares of Healthpeak Properties by 23.5% during the first quarter. Cohen & Steers Inc. now owns 70,123,019 shares of the company’s stock worth $2,225,742,000 after purchasing an additional 13,345,452 shares in the last quarter. Geode Capital Management LLC grew its holdings in Healthpeak Properties by 1.0% during the 1st quarter. Geode Capital Management LLC now owns 10,381,809 shares of the company’s stock worth $328,704,000 after acquiring an additional 104,241 shares in the last quarter. Dimensional Fund Advisors LP grew its position in shares of Healthpeak Properties by 0.3% in the 1st quarter. Dimensional Fund Advisors LP now owns 7,839,036 shares of the company’s stock worth $248,814,000 after acquiring an additional 26,047 shares in the last quarter. American Century Companies Inc. raised its holdings in shares of Healthpeak Properties by 6.5% during the second quarter. American Century Companies Inc. now owns 6,582,669 shares of the company’s stock worth $219,137,000 after purchasing an additional 400,319 shares during the period. Finally, Baupost Group LLC MA raised its position in shares of Healthpeak Properties by 24.2% during the 1st quarter. Baupost Group LLC MA now owns 4,966,911 shares of the company’s stock worth $157,650,000 after purchasing an additional 966,711 shares during the period. 92.79% of the stock is currently owned by institutional investors and hedge funds.
A number of equities research analysts have recently weighed in on PEAK shares. Wells Fargo & Company lifted their price target on Healthpeak Properties from $32.00 to $36.00 and gave the company an “underweight” rating in a report on Friday, July 23rd. Mizuho reissued a “neutral” rating and issued a $32.00 price target on shares of Healthpeak Properties in a research note on Wednesday, July 14th. Argus upped their price objective on shares of Healthpeak Properties from $34.00 to $39.00 and gave the stock a “buy” rating in a report on Tuesday, June 15th. Royal Bank of Canada boosted their target price on Healthpeak Properties from $36.00 to $39.00 and gave the stock an “outperform” rating in a report on Tuesday, August 17th. Finally, Morgan Stanley increased their price target on Healthpeak Properties from $32.00 to $37.00 and gave the company an “equal weight” rating in a research note on Monday, September 13th. One research analyst has rated the stock with a sell rating, four have issued a hold rating and seven have issued a buy rating to the stock. Based on data from MarketBeat.com, Healthpeak Properties currently has a consensus rating of “Buy” and an average target price of $34.85.
The company also recently disclosed a quarterly dividend, which was paid on Friday, August 20th. Shareholders of record on Monday, August 9th were issued a dividend of $0.30 per share. This represents a $1.20 annualized dividend and a yield of 3.48%. The ex-dividend date was Friday, August 6th. Healthpeak Properties’s dividend payout ratio is 73.17%.
Healthpeak Properties Profile
Healthpeak Properties, Inc is a real estate investment trust, which invests primarily in real estate serving the healthcare industry in the United States. It acquires, develops, leases, sells, and manages healthcare real estate and provides mortgage and other financing to healthcare providers. It operates through the following business segments: Life Science, Medical Office and Continuing Care Retirement Community(CCRC).
Further Reading: Investing in Blue-Chip Stocks
Receive News & Ratings for Healthpeak Properties Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthpeak Properties and related companies with MarketBeat.com's FREE daily email newsletter.